Policymakers need to catch up with the explosion of new tests and therapies
The field of endocrinology has expanded dramatically in the past 40 years, both because of increased knowledge about the aetiology, diagnosis and therapy of endocrine disease and because of the increasing number of patients with very common endocrine conditions, particularly type 2 diabetes, osteoporosis and menopausal problems.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1 Austin and Repatriation Medical Centre, Melbourne, VIC.
- 2 Garvan Institute of Medical Research, Sydney, NSW.
- 3 The Medical Journal of Australia, Sydney, NSW.
Correspondence:
- 1. Dunstan D, Zimmet P, Welborn T, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829–834.
- 2. Access Economics. The burden of brittle bones: costing osteoporosis in Australia. Prepared for Osteoporosis Australia by Access Economics Pty Ltd. Canberra: Access Economics, 2001.
- 3. Neer, RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteo-porosis. N Engl J Med 2001; 344: 1434-1441.
Online responses are no longer available. Please refer to our instructions for authors page for more information.